Related Experiment Video

Updated: May 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor

Naoteru Miyata1, Toshifumi Azuma, Shigenari Hozawa

  • 1Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. bluebirdmiyata@hotmail.com

Pancreas
|March 24, 2012
PubMed
Abstract

Insights

Lefty acts as a tumor suppressor in pancreatic cancer by responding to transforming growth factor-beta (TGF-β). The Ras/MEK/ERK pathway inhibits this TGF-β-Lefty signaling, suggesting combination therapy for treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Signal Transduction

Background:

  • Transforming growth factor-beta (TGF-β) signaling plays a complex role in cancer, often acting as a tumor suppressor.
  • The Ras/MEK/ERK pathway is frequently hyperactivated in various cancers, promoting cell proliferation.
  • Understanding the interplay between these pathways is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To identify a novel tumor suppressor gene regulated by TGF-β in pancreatic cancer.
  • To investigate the role of the Ras/MEK/ERK signaling pathway in modulating TGF-β-dependent Lefty gene expression.

Main Methods:

  • Utilized human pancreatic cancer cell lines.
  • Assessed TGF-β-mediated Lefty up-regulation.
  • Manipulated the Ras/MEK/ERK pathway using small interfering RNA (siRNA) and specific inhibitors (U0126, LY294002).

Main Results:

  • TGF-β treatment significantly upregulated Lefty messenger RNA (mRNA) in most tested cell lines.
  • Recombinant Lefty demonstrated an inhibitory effect on Nodal-mediated proliferation, indicating tumor suppressor activity.
  • Inhibition of the Ras/MEK/ERK pathway markedly enhanced TGF-β-induced Lefty up-regulation, revealing pathway crosstalk.

Conclusions:

  • Lefty is identified as a novel TGF-β target gene that inhibits pancreatic cancer cell growth.
  • Activation of the Ras/MEK/ERK pathway represents a mechanism for pancreatic cancer to evade TGF-β-Lefty-mediated growth inhibition.
  • Combination therapy involving Ras/MEK/ERK inhibitors and TGF-β presents a potential therapeutic strategy for pancreatic cancer.

More Related Videos

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor07:16

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor

Published on: September 13, 2018

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...